Fierce Pharma

MAY 30, 2024

As various efforts to produce next-generation vaccines in Africa are being carried forward by the likes of the World Health Organization (WHO) and the Bill & Melinda Gates Foundation, BioNTech | Under an expansion of the partners’ existing deal, the Coalition for Epidemic Preparedness Innovations (CEPI) is committing up to $145 million to bolster BioNTech’s efforts to establish vaccine R&D and manufacturing capabilities at the German company’s facility in Kigali, Rwanda.

Manufacturing 323

Manufacturing 323

MedCity News

MAY 30, 2024

Mental health inequities are costing the U.S. $477.5 billion annually. This could rise to $1.3 trillion in 2040 if left unaddressed. The post Mental Health Inequities Could Cost $1.3 Trillion in 2040. How Can the Industry Prevent This? appeared first on MedCity News.

Medical 132

Medical 132

Fierce Pharma

MAY 30, 2024

The United States Department of Health and Human Services has expanded its avian flu pandemic preparedness partnership with CSL Seqirus, lining up the vaccine specialist to

Government 308

Government 308

pharmaphorum

MAY 30, 2024

COVID-19 vaccination rates have fallen precipitously in Europe and should be ramped up this autumn so they are at least in line with influenza vaccine uptake.

137

137

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

MAY 30, 2024

In the span of half a year, Gilead Sciences' Trodelvy has flopped a second phase 3 trial. | Following a high-profile lung cancer setback in January, Gilead said Thursday that Trodelvy also failed to move the needle in a bladder cancer study. The flop threatens the ADC's accelerated approval in the tumor type.

296

296

MedCity News

MAY 30, 2024

A pending CMS policy could cause havoc for independent kidney care facilities and patients who need life-sustaining treatments. The post Protect Personalized, Independent Kidney Care appeared first on MedCity News.

Patients 119

Patients Physicians 119

PharmaVoice

MAY 30, 2024

To lower drug prices, lawmakers are turning to the drug patent system to outlaw some common practices — but a former patent agency director says it’s the wrong way to go.

111

111

Fierce Pharma

MAY 30, 2024

With a target date for FDA approval less than a month away, Sanofi and Regeneron’s megablockbuster Dupixent has gained much attention as it is on the verge of becoming the first biologic to treat c | With Verona Pharmaceuticals' COPD candidate ensifentrine approaching its FDA decision date, GlobalData has referred to it as a “paradigm shift in COPD treatment.

FDA 282

FDA Pharmaceutical 282

MedCity News

MAY 30, 2024

Plenful has completed a $17 million Series A funding round, bringing its total fundraising amount to date to more than $25 million. The startup offers a software platform that automates the manual and administrative tasks that burden pharmacists and pharmacy technicians. The post Plenful Raises $17M to Help Curb Rising Levels of Pharmacy Burnout appeared first on MedCity News.

115

115

Fierce Pharma

MAY 30, 2024

With results from a head-to-head study comparing its newer chronic myeloid leukemia (CML) treatment Scemblix to its own standard-of-care tyrosine kinase inhibitor (TKI) Gleevec in newly diagnosed p | Newly diagnosed chronic myeloid leukemia patients on Scemblix achieved a major molecular response rate of 68% at 48 weeks compared to 49% for older drugs, including Novartis' established Gleevec.

Patients 214

Patients 214

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

MAY 30, 2024

The US Congress has passed the first-ever federal bill dedicated to ending Parkinson’s disease, modelled on similar legislation for Alzheimer’s enacted in 2011

115

115

Fierce Pharma

MAY 30, 2024

Gilead Sciences is drawing back the curtain on the Trodelvy lung cancer data that previously caused a 10% slide in the company’s stock price. | Gilead Sciences is drawing back the curtain on the Trodelvy lung cancer data that previously caused a 10% slide in the company’s stock price. In sharing the detailed results, the company is hanging onto a positive sign in a subgroup of patients who have a high unmet medical need.

FDA 144

FDA Medical Patients 144

MedCity News

MAY 30, 2024

Hospitals and health systems stand at the forefront of advancing health equity and carry the heavy responsibility of treating illness while promoting wellness and reducing disparities in health outcomes. The post The Vital Role of Hospitals in Tackling Health Inequities appeared first on MedCity News.

111

111

European Pharmaceutical Review

MAY 30, 2024

A novel drug delivery method combining proline and metal such as palladium, could enable chemotherapy drugs to be transported in the body via nano-sized cages. Practically, this could enable delivering the structure “more directly” to a tumour, while “shielding healthy cells”. Chemotherapy drugs, antibiotics, as well as antivirals could be transported using this delivery system , the authors theorised.

Side effects 97

Side effects Transportation Medicine Pharmaceutical 97

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

MedCity News

MAY 30, 2024

CinRx Pharma’s most prominent spinout is CinCor Pharma, which was acquired by AstraZeneca last year. The startup creator will apply its new capital toward current programs and to expand to additional areas of unmet medical need. The post CinRx Pharma Corrals $73M to Continue ‘Hub and Spoke’ Model of Startup Formation appeared first on MedCity News.

Pharma 107

Pharma Medical Biopharma 107

Pharmaceutical Technology

MAY 30, 2024

The US FDA approved Teva Pharmaceuticals’ AUSTEDO XR as a once-daily treatment option for tardive dyskinesia and Huntington’s disease chorea.

Pharmaceutical 105

Pharmaceutical FDA 105

pharmaphorum

MAY 30, 2024

The first patient has received a BioNTech colorectal cancer vaccine as part of the NHS Cancer Vaccine Launch Pad (CVLP) 'matchmaker' service

Patients 105

Patients 105

Pharmaceutical Commerce

MAY 30, 2024

These advancements continue to act as a key driver in helping to boost the security, efficiency, and innovation of global industries, include pharma.

Pharma 102

Pharma 102

Advertisement

pharmaphorum

MAY 30, 2024

Johnson & Johnson's seltorexant hits the mark in a phase 3 trial involving patients with depression and sleep disturbances

Patients 103

Patients 103

MedCity News

MAY 30, 2024

A group of 24 novel startups were selected to pitch at MedCity News’ INVEST conference in Chicago. Here’s four that VC judges chose as the winners in their respective tracks. The post Here’s Why VC Judges Chose These 4 Startups as INVEST Pitch Perfect Winners appeared first on MedCity News.

Biopharma 93

Biopharma Pharma 93

PharmaTech

MAY 30, 2024

A combination of rapid sterility methods with the industry standard compendial method should ensure maximum safety.

Safety 97

Safety 97

pharmaphorum

MAY 30, 2024

In this podcast interview with Dr. Fred Aslan from Artiva Biosciences, explore the potential of NK cells in cell therapy and how they could revolutionise the field of immunotherapy beyond CAR-T therapies.

76

76

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmaTimes

MAY 30, 2024

Affecting the immune system, various forms of SCID are estimated to affect one in 75,000 to 100,000 newborns

93

93

PharmaTech

MAY 30, 2024

Bkemv (eculizumab-aeeb) is the first interchangeable biosimilar to Soliris (eculizumab) to treat paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.

FDA 69

FDA 69

PharmaTimes

MAY 30, 2024

The first phase of the programme will be in place in hospitals across the UK by March 2025

Safety 98

Safety Patients Healthcare Healthcare 98

pharmaphorum

MAY 30, 2024

The US FDA has given accelerated approval for Eli Lilly’s RET inhibitor as a treatment for various RET-altered paediatric cancers, making it the first drug in the class available for children aged under 12. Retevmo (selpercatinib) can now be used to treat RET-positive thyroid cancers and other solid tumours with the mutation, regardless of their type.

FDA 65

FDA 65

Advertisement

Distribution

Clarivate

MAY 30, 2024

In the ever-evolving landscape of intellectual property (IP) litigation, Non-Practicing Entities (NPEs) continue to play an active role and remain on the radar of the world’s largest patent holders. Through new research, Clarivate sheds light on the latest NPE litigation data, unveiling novel trends and insights. The 2018 NPE report: A prelude In 2018, Clarivate published a groundbreaking NPE Report that uncovered a dual trend: NPE litigation was not only extensive in the U.S. but also gaining t

Leads 59

Leads Manufacturing 59

European Pharmaceutical Review

MAY 30, 2024

Download this report to discover key developments impacting cell and gene therapy (CGT) manufacturing. Articles explore how the rapid expansion of the cell and gene therapy field has affected skills, recruitment and training needs; delve into manufacturing and quality requirements for CGTs, and explore how these new modalities are transforming clinical trials.

Pharma 59

Pharma Recruitment Manufacturing Training 59

Pharmaceutical Commerce

MAY 30, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma Healthcare Healthcare 105

Pharmaceutical Technology

MAY 30, 2024

BioNTech and CEPI have announced an expansion of their strategic partnership, aiming to strengthen the mRNA vaccine ecosystem in Africa.

64

64

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales